Transitioning from Testosterone Pellets to Topical Testosterone

Initial Dosing Strategy

• The American Urological Association recommends starting with the standard dose of 50 mg daily (one 5-g packet of AndroGel 1%) applied to the shoulders, upper arms, or abdomen, regardless of unknown pellet dosing 3, 2
• The standard dose range for AndroGel 1% is 50-100 mg daily, providing flexibility for upward titration 3, 2

Monitoring and Dose Adjustment Protocol

• Measure total testosterone levels 2-3 months after initiating topical therapy to allow steady-state levels to be achieved 1, 2
• Target testosterone levels should be in the middle tertile of normal range: 450-600 ng/dL 1, 2
• If testosterone levels are below 450 ng/dL at the 2-3 month check, increase to 75 mg daily (7.5-g gel) 3, 2

Safety Monitoring Beyond Testosterone Levels

• Monitor prostate-specific antigen (PSA) in men over 40 years old 3, 1
• Assess for cardiovascular symptoms at each visit, though current evidence does not definitively demonstrate increased cardiovascular risk with testosterone therapy 1

Common Pitfalls to Avoid

• Warn patients about transfer risk to partners and children through skin-to-skin contact, which is the primary disadvantage of topical formulations compared to pellets 3, 1
• Instruct patients to wash hands immediately after application and cover the application site with clothing once dry 1

Advantages of This Transition Approach

• Topical testosterone provides more stable testosterone levels compared to the fluctuations seen with pellets near the end of their dosing interval 3
• Dose adjustments are simple and immediate, unlike pellets which require a surgical procedure for removal or adjustment 3
• The 50 mg starting dose minimizes risk of supraphysiologic levels while the monitoring protocol ensures adequate replacement 1, 2